US · LIMN
Liminatus Pharma, Inc. Class A Common Stock
Price · as of 2026-09-04
$3.71
Market cap 2.76M
Price history
| Week | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 28, 2025 – May 2, 2025 | $5.01 | $16.44 | $5.01 | $8.04 | 0 |
| May 5, 2025 – May 9, 2025 | $7.60 | $7.99 | $5.50 | $7.45 | 0 |
| May 12, 2025 – May 16, 2025 | $8.22 | $9.40 | $5.75 | $6.45 | 0 |
| May 19, 2025 – May 23, 2025 | $6.59 | $6.71 | $5.03 | $5.56 | 0 |
| May 26, 2025 – May 30, 2025 | $5.85 | $6.59 | $4.40 | $5.43 | 0 |
| Jun 2, 2025 – Jun 6, 2025 | $5.30 | $25.00 | $4.55 | $24.22 | 0 |
| Jun 9, 2025 – Jun 13, 2025 | $22.55 | $26.68 | $10.80 | $14.42 | 0 |
| Jun 16, 2025 – Jun 20, 2025 | $14.42 | $16.13 | $11.73 | $14.43 | 0 |
| Jun 23, 2025 – Jun 27, 2025 | $13.97 | $33.66 | $9.00 | $9.48 | 0 |
| Jun 30, 2025 – Jul 3, 2025 | $11.00 | $12.90 | $8.74 | $9.02 | 0 |
| Jul 7, 2025 – Jul 11, 2025 | $9.00 | $9.00 | $5.05 | $6.65 | 0 |
| Jul 14, 2025 – Jul 18, 2025 | $6.55 | $6.90 | $5.25 | $5.42 | 0 |
| Jul 21, 2025 – Jul 25, 2025 | $5.91 | $9.38 | $5.44 | $8.71 | 0 |
| Jul 28, 2025 – Aug 1, 2025 | $8.72 | $8.89 | $5.85 | $5.93 | 0 |
| Aug 4, 2025 – Aug 8, 2025 | $6.02 | $6.31 | $4.20 | $4.42 | 0 |
| Aug 11, 2025 – Aug 15, 2025 | $4.42 | $4.85 | $3.70 | $4.00 | 0 |
| Aug 18, 2025 – Aug 22, 2025 | $4.05 | $4.12 | $2.53 | $3.41 | 0 |
| Aug 25, 2025 – Aug 29, 2025 | $3.21 | $3.60 | $2.61 | $2.71 | 0 |
| Sep 1, 2025 – Sep 5, 2025 | $2.95 | $3.09 | $2.67 | $2.67 | 0 |
| Sep 8, 2025 – Sep 12, 2025 | $2.60 | $2.60 | $1.82 | $2.00 | 0 |
| Sep 15, 2025 – Sep 19, 2025 | $1.98 | $1.98 | $1.23 | $1.26 | 0 |
| Sep 22, 2025 – Sep 26, 2025 | $1.15 | $1.74 | $1.12 | $1.45 | 0 |
| Sep 29, 2025 – Oct 3, 2025 | $1.50 | $2.09 | $1.49 | $1.73 | 0 |
| Oct 6, 2025 – Oct 10, 2025 | $1.76 | $1.77 | $1.36 | $1.41 | 0 |
| Oct 13, 2025 – Oct 17, 2025 | $1.43 | $1.50 | $1.11 | $1.15 | 0 |
| Oct 20, 2025 – Oct 24, 2025 | $1.16 | $1.39 | $1.11 | $1.24 | 0 |
| Oct 27, 2025 – Oct 31, 2025 | $1.26 | $1.70 | $1.17 | $1.39 | 0 |
| Nov 3, 2025 – Nov 7, 2025 | $1.40 | $1.40 | $1.13 | $1.17 | 0 |
| Nov 10, 2025 – Nov 14, 2025 | $1.20 | $1.24 | $1.02 | $1.07 | 0 |
| Nov 17, 2025 – Nov 21, 2025 | $1.07 | $1.30 | $0.61 | $0.72 | 0 |
| Nov 24, 2025 – Nov 28, 2025 | $0.73 | $1.06 | $0.72 | $1.04 | 0 |
| Dec 1, 2025 – Dec 5, 2025 | $1.07 | $1.07 | $0.71 | $0.84 | 0 |
| Dec 8, 2025 – Dec 12, 2025 | $0.91 | $0.92 | $0.83 | $0.85 | 0 |
| Dec 15, 2025 – Dec 19, 2025 | $0.87 | $0.88 | $0.76 | $0.79 | 0 |
| Dec 22, 2025 – Dec 26, 2025 | $0.79 | $0.80 | $0.64 | $0.65 | 0 |
| Dec 29, 2025 – Jan 2, 2026 | $0.63 | $0.68 | $0.61 | $0.64 | 0 |
| Jan 5, 2026 – Jan 9, 2026 | $0.67 | $0.94 | $0.67 | $0.73 | 0 |
| Jan 12, 2026 – Jan 16, 2026 | $0.77 | $0.83 | $0.74 | $0.77 | 0 |
| Jan 19, 2026 – Jan 23, 2026 | $0.77 | $0.80 | $0.69 | $0.77 | 0 |
| Jan 26, 2026 – Jan 30, 2026 | $0.77 | $0.77 | $0.54 | $0.55 | 0 |
| Feb 2, 2026 – Feb 6, 2026 | $0.57 | $2.63 | $0.54 | $1.84 | 0 |
| Feb 9, 2026 – Feb 13, 2026 | $1.99 | $2.83 | $0.35 | $0.38 | 0 |
| Feb 16, 2026 – Feb 20, 2026 | $0.25 | $0.28 | $0.21 | $0.23 | 0 |
| Feb 23, 2026 – Feb 27, 2026 | $0.23 | $0.27 | $0.22 | $0.25 | 0 |
| Mar 2, 2026 – Mar 6, 2026 | $0.25 | $0.28 | $0.21 | $0.23 | 0 |
| Mar 9, 2026 – Mar 13, 2026 | $0.24 | $0.27 | $0.23 | $0.23 | 0 |
| Mar 16, 2026 – Mar 20, 2026 | $0.24 | $0.25 | $0.19 | $0.21 | 0 |
| Mar 23, 2026 – Mar 27, 2026 | $0.21 | $0.22 | $0.18 | $0.19 | 0 |
| Mar 30, 2026 – Apr 2, 2026 | $0.18 | $0.19 | $0.16 | $0.18 | 0 |
| Apr 6, 2026 – Apr 10, 2026 | $0.19 | $0.21 | $0.18 | $0.19 | 0 |
| Apr 13, 2026 – Apr 17, 2026 | $0.19 | $0.24 | $0.18 | $0.22 | 0 |
| Apr 20, 2026 – Apr 24, 2026 | $0.21 | $0.23 | $0.19 | $0.20 | 0 |
| Apr 27, 2026 – May 1, 2026 | $0.20 | $0.21 | $0.20 | $0.21 | 0 |
| May 4, 2026 – May 8, 2026 | $0.20 | $0.23 | $0.20 | $0.20 | 0 |
| May 11, 2026 – May 15, 2026 | $0.20 | $0.21 | $0.18 | $0.18 | 0 |
| May 18, 2026 – May 22, 2026 | $0.19 | $0.36 | $0.13 | $0.17 | 0 |
| May 25, 2026 – May 29, 2026 | $0.17 | $0.19 | $0.16 | $0.16 | 0 |
| Jun 1, 2026 – Jun 5, 2026 | $0.17 | $0.21 | $0.14 | $0.14 | 0 |
| Jun 8, 2026 – Jun 12, 2026 | $0.14 | $0.15 | $0.12 | $0.12 | 0 |
| Jun 15, 2026 – Jun 18, 2026 | $0.12 | $0.13 | $0.11 | $0.12 | 0 |
| Jun 22, 2026 – Jun 26, 2026 | $0.12 | $0.12 | $0.10 | $0.11 | 0 |
| Jun 29, 2026 – Jul 2, 2026 | $0.11 | $0.21 | $0.10 | $0.14 | 0 |
| Jul 6, 2026 – Jul 10, 2026 | $0.16 | $0.16 | $0.11 | $0.11 | 0 |
| Jul 13, 2026 – Jul 17, 2026 | $0.11 | $0.20 | $0.10 | $0.12 | 0 |
| Jul 20, 2026 – Jul 24, 2026 | $0.12 | $0.13 | $0.11 | $0.11 | 0 |
| Jul 27, 2026 – Jul 31, 2026 | $0.11 | $5.50 | $0.10 | $5.15 | 0 |
| Aug 3, 2026 – Aug 7, 2026 | $5.20 | $6.36 | $4.80 | $5.15 | 0 |
| Aug 10, 2026 – Aug 14, 2026 | $5.03 | $9.20 | $4.99 | $7.00 | 0 |
| Aug 17, 2026 – Aug 21, 2026 | $6.58 | $7.48 | $5.15 | $5.16 | 0 |
| Aug 24, 2026 – Aug 28, 2026 | $5.03 | $5.04 | $4.23 | $4.23 | 0 |
| Aug 31, 2026 – Sep 4, 2026 | $4.24 | $4.26 | $3.42 | $3.71 | 0 |
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | -0.54 | |
| P/B | -0.56 | |
| P/S | — | |
| EV/EBITDA | -0.66 | |
| PEG | -7.23 | |
| P/TBV | -0.56 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $0.23 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
- CEO
- Chris Kim
- Employees
- 1
- Beta
- 0.74
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| LIMN | Liminatus Pharma, Inc. Cl… | $0.10 | 2.76M | — | — | -0.54 | -0.56 | — | -0.66 | -7.23 | -0.56 | 0.00% | 0.00% | 0.00% | 79.48% | 29.29% | -610.85% | -0.15 | -13.75 | 0.05 | 0.03 | -0.11 | 7.50% | — | 221.15% | -180.26% | -0.97 | 98.47% | 0.00% | 0.00% | 58.05% | -2.24 | -0.67 | — | -147.83 |
| ATHE | Alterity Therapeutics Lim… | $4.45 | 75.39M | $11.05 | +148% | -6.29 | 1.80 | 14.06 | -2.46 | — | 1.80 | 97.66% | -267.96% | -223.35% | -43.23% | -905.76% | -37.23% | 0.00 | — | 12.98 | 12.62 | 2.26 | -63.46% | 35.32% | -9.20% | -14.98% | -3.24 | -711.67% | 0.00% | 0.00% | 26.85% | -2.47 | -3.14 | 6.61 | 5.97 |
| BTAI | BioXcel Therapeutics, Inc… | $0.90 | 27.84M | $10.67 | +1,083% | -0.26 | -0.19 | 28.33 | -1.89 | — | -0.19 | 74.45% | -7829.75% | -10887.38% | 74.14% | 293.73% | -167.91% | -1.15 | -2.96 | 0.83 | 0.53 | -1.54 | -75.63% | -71.67% | -20.01% | -316.74% | -1.07 | 336.66% | 0.00% | 0.00% | 0.00% | -1.98 | -1.73 | 154.88 | -26.29 |
| DYAI | Dyadic International, Inc… | $1.00 | 36.44M | $13.93 | +1,293% | -3.37 | 20.12 | 20.12 | -3.26 | -22.44 | 20.12 | -88.25% | -579.88% | -597.63% | -397.80% | 518.81% | -74.11% | 4.11 | -15.67 | 2.68 | 2.29 | -0.06 | 15.00% | -64.74% | 43.46% | -23.00% | -1.55 | 413.99% | 0.00% | 0.00% | 0.00% | -3.15 | -3.95 | 18.29 | -12.95 |
| EVAX | Evaxion Biotech A/S | $3.10 | 19.58M | $0.75 | -76% | -3.53 | 1.60 | 3.63 | -1.62 | — | 1.60 | 100.00% | -122.66% | -102.38% | -100.48% | -351.08% | -37.81% | 0.44 | -10.54 | 5.85 | 5.70 | 2.21 | -87.65% | 125.12% | -48.56% | -24.38% | -1.56 | -282.89% | 0.00% | 0.00% | 76.12% | -1.25 | -1.74 | 1.54 | -4.72 |
| JSPR | Jasper Therapeutics, Inc. | $0.71 | 11.53M | — | — | -0.31 | 5.63 | — | 0.05 | — | 5.63 | 0.00% | 0.00% | 0.00% | -230.31% | 511.94% | -131.06% | 0.30 | — | 2.62 | 2.17 | 0.37 | -19.22% | — | 22.19% | -329.99% | -5.85 | 490.64% | 0.00% | 0.00% | 0.00% | 0.05 | 0.05 | — | -18.65 |
| SABS | SAB Biotherapeutics, Inc. | $3.90 | 37.28M | $0.65 | -83% | 6.04 | 0.53 | — | -0.63 | — | 0.53 | 0.00% | 0.00% | 0.00% | 14.96% | -138.42% | 12.23% | 0.04 | -203.41 | 9.46 | 9.13 | -0.27 | -78.53% | -100.00% | 31.99% | -57.03% | -4.19 | -129.25% | 0.00% | 0.00% | 0.40% | 0.21 | 0.23 | — | 1.05 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $3.71) − 1 = — (IC, example).